VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AVTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AVTXAvalo Therapeutics, Inc.
$19.25$217M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAVTXPrice History

AVTX logoAvalo Therapeutics, Inc. (AVTX) Stock Price History

Historical prices from 2015 to 2026

$19.25-0.71  (-3.56%)close Jul 7
Returns
1M
+51.1%
3M
+20.9%
YTD
+13.1%
1Y
+305.3%
3Y
-39.2%
5Y
-70.7%
ATH$22,032.00Feb 2019-99.9%
ATL$3.39May 2025pre-split
Avg Vol (50D)2.0M/ day
52-Week Range$4.61 — $24.25
LowCurrent: $19.25High

Loading 10-year price history...

AVTX Historical Performance

1 YearTotal Return
+305.3%
Price: +305.3%
3 YearsTotal Return
-77.5%
CAGR: -39.2%
Price: -77.5%
5 YearsTotal Return
-99.8%
CAGR: -70.7%
Price: -99.8%
YTD
+13.1%

AVTX Annual Returns

Year-by-year price performance · 2015–2026

Best+259.6%2017
Worst-99.2%2023
Up years4/12
2015-48.5%
2016-77.1%
2017+259.6%
2018-3.0%
2019+54.4%
2020-47.5%
2021-35.6%
2022-76.8%
2023-99.2%
2024-14.7%
2025+115.4%
2026+2.8%
2015 annual price return
-48.5%
2016 annual price return
-77.1%
2017 annual price return
+259.6%
2018 annual price return
-3.0%
2019 annual price return
+54.4%
2020 annual price return
-47.5%
2021 annual price return
-35.6%
2022 annual price return
-76.8%
2023 annual price return
-99.2%
2024 annual price return
-14.7%
2025 annual price return
+115.4%
2026 annual price return
+2.8%
LessMore
Alpha vs S&P 500
1Y+246.6%
3Y-93.7%
5Y-83.6%

Price returns only.

Download Historical Data

2,697 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

AVTX Stock Price Trajectory (2015–2026)

As of July 8, 2026, Avalo Therapeutics, Inc. (AVTX) trades at $19.25, representing a +305.3% return over the past year. The stock has delivered a -99.8% total return over five years (-70.7% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $22,032.00 on February 27, 2019. From this peak, AVTX has corrected -99.9%, currently trading 20% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers IMVT (+144.2% 1Y), ARQT (+106.6% 1Y), and KYMR (+172.2% 1Y), AVTX has underperformed the peer group average. Compare AVTX vs IMVT →

AVTX Historical Price Data · from 2015

Rows 1–50 of 2,697
Date Open High Low Close Volume Change %
2026-07-0720.4020.6519.2119.251.44M-3.56%
2026-07-0619.4420.3019.3019.961.61M+5.94%
2026-07-0217.4518.9617.2718.841.81M+8.96%
2026-07-0118.4318.9917.2417.291.85M-6.44%
2026-06-3019.4520.1018.3018.482.38M-4.20%
2026-06-2918.2519.4817.9519.291.57M+5.99%
2026-06-2618.2918.4617.6518.200+1.11%
2026-06-2518.1718.6917.8918.001.69M-1.04%
2026-06-2418.2518.4117.7718.191.29M+2.02%
2026-06-2316.8018.5416.7117.831.91M+4.39%
2026-06-2214.8617.4114.7117.082.51M+16.19%
2026-06-1815.9315.9314.5914.704.25M-4.55%
2026-06-1714.4115.5014.2715.401.16M+7.47%
2026-06-1614.5914.6814.0014.331.50M-1.85%
2026-06-1515.1315.2314.5114.60924K-1.08%
2026-06-1214.0214.8514.0214.761.10M+7.97%
2026-06-1113.0913.8813.0013.67817K+4.35%
2026-06-1012.8013.2712.8013.101.41M+1.55%
2026-06-0912.9313.4312.5212.901.30M+1.26%
2026-06-0813.2513.6112.6912.741.04M-2.75%
2026-06-0513.4413.7612.8913.101.76M-3.75%
2026-06-0413.7514.3713.2913.611.34M-0.95%
2026-06-0314.2014.7113.6513.741.46M-1.58%
2026-06-0215.4415.6213.7913.961.60M-11.37%
2026-06-0115.8816.4115.6015.75824K-1.25%
2026-05-2916.0916.4015.6715.951.05M-1.12%
2026-05-2815.7916.3015.2716.131.74M+2.15%
2026-05-2715.9916.4815.7115.79901K-1.44%
2026-05-2616.3616.5715.9516.021.31M-2.02%
2026-05-2216.6017.0116.0216.351.31M-1.51%
2026-05-2116.0717.1015.9316.601.35M+1.90%
2026-05-2016.3317.0116.0916.291.30M+0.12%
2026-05-1916.2017.2115.2916.271.63M+0.68%
2026-05-1817.7317.9015.5216.162.54M-8.91%
2026-05-1518.7619.0017.4117.741.53M-6.68%
2026-05-1419.7319.7718.7719.011.70M-4.23%
2026-05-1320.2120.2119.3919.851.56M-0.45%
2026-05-1220.2520.9019.4919.941.69M-1.53%
2026-05-1121.8622.0219.8020.252.85M-6.12%
2026-05-0822.7422.9720.9821.571.73M-5.68%
2026-05-0722.3024.2521.3122.875.20M+4.86%
2026-05-0622.8023.7117.6921.8121.25M+34.13%
2026-05-0513.8716.2813.8716.26250K+18.00%
2026-05-0413.5514.1613.5213.78394K+0.51%
2026-05-0113.5314.0212.9713.71720K+2.31%
2026-04-3013.0213.5412.5513.40706K+1.52%
2026-04-2912.8613.5312.5113.20750K+2.64%
2026-04-2814.5015.0912.6312.86814K-10.82%
2026-04-2713.9214.8213.9014.42658K+3.59%
2026-04-2414.7515.1113.7313.92742K-5.63%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

AVTX — Frequently Asked Questions

Quick answers to the most common questions about buying AVTX stock.

How has AVTX stock performed recently?

AVTX returned +305.3% over the past year, beating its 5-year annualized CAGR of -70.7%. The stock trades above its 200-day moving average, confirming the uptrend.

What is AVTX's all-time high price?

Avalo Therapeutics, Inc. reached $22032.00 on 2019-02-27. The 52-week high is $24.25. Current 1-year return of +305.3% places the stock closer to historical peaks.

Where can I download AVTX historical price data?

This page provides AVTX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2015-2026, downloadable in CSV format.

451 data points · sampled from 2,697